Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Statement regarding Elektron Technology plc

17 Jun 2014 07:00

RNS Number : 7602J
Microgen PLC
17 June 2014
 

microgen

www.microgen.com

 

17 June 2014

 

 

 

STATEMENT REGARDING ELEKTRON TECHNOLOGY PLC

 

Announcement falling under Rule 2.8 of the City Code on Takeovers and Mergers (the "Code")

 

Microgen plc ("Microgen") announced its interest in exploring opportunities consistent with the Elektron Technology plc ("Elektron") Strategic Alternatives Process ("SAP") on 20 May 2014 and provided a further update on 27 May 2014.

 

Microgen submitted its original proposal to the Board of Elektron on 2 May 2014 ("Refinancing Proposal"). The Refinancing Proposal indicated, subject to due diligence information being provided and other terms typical of a transaction of this nature, that Microgen could make a potential equity-based investment of between £12 million and £18 million and that Elektron would remain listed on AIM. Further information in respect of this proposal was detailed in Microgen's announcement of 20 May 2014.

 

The Refinancing Proposal was rejected by the Board of Elektron on 7 May 2014 who also then advised that, contrary to the SAP announcement, only offers for the entire issued share capital of Elektron would be considered. Following Microgen's announcement of 20 May 2014, access to due diligence information was progressed allowing Microgen to determine whether or not it was able to submit such an offer.

 

Whilst Microgen's preferred structure remains the Refinancing Proposal, on 11 June 2014 Microgen submitted to the Board of Elektron a non-binding letter with details of a potential offer by Microgen for the entire issued share capital of Elektron ("Offer Proposal"). Microgen's Offer Proposal was, subject to a number of conditions typical of a transaction of this nature, to make an offer for all of the issued equity of Elektron at a price of 5 pence per share in cash. This would represent:

 

· A value for the existing issued ordinary share capital of Elektron of approximately £6.0 million equivalent to an enterprise value for Elektron, adjusting for net debt at 30 April 2014, of £13.6 million. (The level of investment required under the Offer Proposal (enterprise value of £13.6 million) is similar in value to that of the Refinancing Proposal (£12 million to £18 million), taking into account investment in additional growth opportunities.)

 

· A premium of approximately 17.6% to the mid-market closing share price of 4.25 pence per Elektron share on 16 June 2014

 

Whilst Microgen's Offer Proposal would have sought to acquire 100% of the issued Elektron shares, any offer would have been declared unconditional as to acceptances once Microgen had received valid acceptances and/or acquired voting share rights representing in excess of 75% of the issued Elektron shares. Microgen's offer would have been funded from Microgen's existing cash resources. The Board of Elektron rejected Microgen's Offer Proposal on 13 June 2014 and did not express any interest in reconsidering Microgen's Refinancing Proposal.

 

Microgen considers that its Offer Proposal reflected fair, and arguably generous, value for Elektron shareholders. However, without a recommendation from the Board of Elektron, Microgen confirms that it is inappropriate to proceed with its Offer Proposal at the present time and therefore Microgen does not intend to make an offer for Elektron. Similarly Microgen cannot proceed with its Refinancing Proposal without the support of the Elektron Board.

 

Microgen stated in its announcement of 20 May 2014 that the Refinancing Proposal, with its investment in the £12 million to £18 million range, "offered Elektron shareholders the opportunity to share in the Elektron recovery from a stable financial platform." Microgen also stated in its announcement of 20 May 2014 that "In view of the cash resources absorbed by Elektron in recent years, the continuing deterioration of Elektron's financial position and the proven inability of Elektron to forecast future business prospects, should Elektron receive only a limited cash injection, this may only provide short-term relief and may not provide the confidence required with non-equity stakeholders (customers, suppliers, banks, employees) to enable Elektron to rebuild". It is therefore disappointing that the Board of Elektron have decided not to progress either of the Microgen proposals.

 

Under Rule 2.8 of the Code, and except with the consent of the Panel, the statement that Microgen does not intend to make an offer for Elektron will prevent Microgen, or anyone acting in concert with it (or any person who is subsequently acting in concert with it or them), from announcing an offer or possible offer for Elektron or taking certain other action within the next six months unless there is, in the opinion of the Panel, a material change of circumstances or there has occurred an event which is specified in Note 2 of Rule 2.8 as enabling this statement to be set aside. Accordingly, for the purposes of Rule 2.8, Microgen reserves the right (on behalf of itself and anyone acting in concert with it) to announce an offer or possible offer for Elektron and/or to take any other action which would otherwise be restricted under Rule 2.8 within the next six months in circumstances set out in Note 2 of Rule 2.8.

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Lucy Delaney, FTI Consulting 020-3727-1131

 

Rowena Murray, Investec Bank plc 020-7597-5970

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRXQLLFZQFLBBL
Date   Source Headline
13th Dec 20194:27 pmRNSHolding(s) in Company
11th Dec 20196:08 pmRNSHolding(s) in Company
10th Dec 20195:18 pmRNSDirector/PDMR Shareholding
10th Dec 20199:47 amRNSDirector Dealings and Related Party Transactions
9th Dec 20194:30 pmRNSHolding(s) in Company
3rd Dec 20192:48 pmRNSCompletion of Tender Offer & Total Voting Rights
26th Nov 20197:00 amRNSResult of Tender Offer
25th Nov 20192:00 pmRNSResult of General Meeting
1st Nov 20197:00 amRNSProposed Tender Offer and Notice of GM
31st Oct 20195:17 pmRNSDirector/PDMR Shareholding
31st Oct 20199:57 amRNSContract Win
28th Oct 20197:00 amRNSHolding(s) in Company
24th Oct 20197:00 amRNSTotal Voting Rights
23rd Oct 20195:06 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHalf-year Report
2nd Oct 20195:15 pmRNSChange of Name
25th Sep 20197:00 amRNSCompletion of Sale of Elektron Technology
3rd Sep 20191:14 pmRNSElektron Technology UK Limited - Disposal update
13th Aug 20194:30 pmRNSDirector/PDMR Shareholding
31st Jul 20192:05 pmRNSSecond Price Monitoring Extn
31st Jul 20192:00 pmRNSPrice Monitoring Extension
31st Jul 20197:00 amRNSSale of Elektron Technology UK Limited
30th Jul 20193:30 pmRNSResult of AGM
5th Jul 20197:00 amRNSPosting of Annual Report & Notice of AGM
19th Jun 20195:02 pmRNSHolding(s) in Company
12th Jun 20197:00 amRNSPreliminary Results
15th May 20197:00 amRNSTrading Update & Notice of Results
15th May 20197:00 amRNSAcquisition
5th Feb 20197:00 amRNSTrading and Strategic Update
18th Dec 20189:05 amRNSBoard Changes
1st Nov 20187:00 amRNSTrading Statement
10th Oct 20181:26 pmRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
28th Aug 20189:55 amRNSHolding(s) in Company
10th Aug 20189:19 amRNSHolding(s) in Company
9th Aug 20187:00 amRNSTrading Statement
24th Jul 20187:00 amRNSCenter Parcs drives up Productivity with Checkit
18th Jul 201811:20 amRNSHolding(s) in Company
20th Jun 20183:20 pmRNSResult of Annual General Meeting
20th Jun 20187:00 amRNSAGM Trading Update
12th Jun 20187:00 amRNSCapital Markets Day
31st May 20187:00 amRNSHolding(s) in Company
30th May 201811:23 amRNSReplacement: Holding(s) in Company
30th May 20189:03 amRNSHolding(s) in Company
18th May 20187:00 amRNSPosting of Annual Report and Notice of AGM
16th May 20187:00 amRNSHolding(s) in Company
10th May 20181:46 pmRNSHolding(s) in Company
3rd May 20187:00 amRNSFinal Results
20th Apr 20187:00 amRNSNotice of Results
10th Apr 20187:00 amRNSCheckit passes £1 million annual recurring revenue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.